| Lipodystrophy Syndrome in Patients with HIV Infection | 2001/01/01 | English | 68 |
| Lipodystrophy Syndrome in HIV Infection | 2000/01/01 | English | 68 |
| Comparative Tolerability of Sulphonylureas in Diabetes Mellitus | 2000/01/01 | English | 68 |
| Drug-Induced Lupus Erythematosus | 2011/05/01 | English | 67 |
| Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs | 2003/01/01 | English | 67 |
| Hepatotoxicity of Antiretrovirals | 2005/01/01 | English | 67 |
| A Risk-Benefit Assessment of Iron-Chelation Therapy | 1997/12/01 | English | 66 |
| Renal Failure Associated with the Use of Celecoxib and Rofecoxib | 2002/01/01 | English | 66 |
| Pharmacovigilance in Perspective | 1999/01/01 | English | 66 |
| Using MedDRA | 2004/01/01 | English | 66 |
| Emergency Department Visits Caused by Adverse Drug Events | 2007/01/01 | English | 66 |
| Antipsychotic-Induced Hyponatraemia | 2010/02/01 | English | 66 |
| Drug-Induced Tinnitus and Other Hearing Disorders | 1996/03/01 | English | 66 |
| The Toxicity of Cytarabine | 1990/01/01 | English | 66 |
| Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to? | 2011/03/01 | English | 66 |
| Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs | 2010/04/01 | English | 66 |
| Postmarketing Safety Surveillance | 2013/02/02 | English | 66 |
| Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management | 2019/03/19 | English | 66 |
| Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works | 2017/07/22 | English | 66 |
| Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data | 2010/06/01 | English | 65 |
| Drug-Induced Diabetes Insipidus | 1999/01/01 | English | 65 |
| Drugs, QT Interval Prolongation and ICH E14 | 2005/01/01 | English | 65 |
| Adverse Effects of Angiotensin Converting Enzyme (ACE) Inhibitors | 1992/01/01 | English | 65 |
| Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance | 2013/10/05 | English | 65 |
| Comparative Tolerability of Newer Agents for Insomnia | 2009/09/01 | English | 65 |
| Anaphylactoid and Anaphylactic Reactions Hazards of β-Blockers | 1995/05/01 | English | 65 |
| Thalidomide in Human Immunodeficiency Virus (HIV) Patients | 1992/01/01 | English | 65 |
| Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma | 2006/01/01 | English | 65 |
| Safety of Inhalation of a 50% Nitrous Oxide/Oxygen Premix | 2006/01/01 | English | 65 |
| Second-Generation Antipsychotics | 2006/01/01 | English | 64 |